What is Mega Lifesciences Public Company Limited's (MEGA.BK) StockRank?

MoatMap's StockRank for Mega Lifesciences Public Company Limited (MEGA.BK) is 98/100, with a Strong Buy signal. This is a composite score combining Quality (81), Value (72), and Momentum (58) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Mega Lifesciences Public Company Limited have an economic moat?

Mega Lifesciences Public Company Limited (MEGA.BK) has a Quality factor score of 81/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Mega Lifesciences Public Company Limited a buy, hold, or sell?

MoatMap's current signal for Mega Lifesciences Public Company Limited (MEGA.BK) is Strong Buy, based on a StockRank of 98/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Mega Lifesciences Public Company Limited in?

Mega Lifesciences Public Company Limited (MEGA.BK) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Thailand).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

MEGA.BK

Strong BuyFull House

Mega Lifesciences Public Company Limited · Healthcare · Thailand · $949M · Avg Vol: $1M/d

StockRank

Get insider-trade alerts

P/E (TTM)

14.0x

ROE

21.6%

D/E

0.1x

Dividend %

4.6%

COMPANY DESCRIPTION

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods.

FINANCIAL SUMMARY (THB)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	15.7B	15.7B	15.3B	14.1B	-3.4%	14.6B	14.3B	15.7B	5.2%
EPS (THB)	2.57	2.29	2.31	2.19	-5.2%	2.52	2.37	2.67	10.4%
Shares	871.9M	871.9M	871.9M	871.9M	0.0%	871.9M	—	—	—
Debt	420.9M	251.8M	491.2M	683.5M	17.5%	696.7M	—	—	—
Equity	8.8B	9.3B	9.9B	10.2B	5.2%	—	—	—	—
Op CF	2.0B	1.9B	2.4B	2.8B	11.5%	2.8B	—	—	—
Inv CF	-280.8M	-250.0M	1.4M	-584.7M	—	—	—	—	—
Fin CF	-1.4B	-1.7B	-1.3B	-1.3B	—	—	—	—	—

Loading 1Y...

PRICE (1Y)-3.7%

SMA 50SMA 200

$1.08

RSI (14)

45.9

52W High

$1.18

From 52W High

0.9%

SCORE BREAKDOWN

Quality

ROIC

26.9%95.3

ROE

21.6%89.9

GP/Assets

48.5%85.6

Op. Margin

17.0%78.6

FCF/Assets

14.0%92.7

Piotroski

668.8

Int. Cover

48.2x78.3

D/E Ratio

0.07x67.8

Current Ratio

2.20x42.5

Value

P/E (TTM)

14.0x76.5

EV/EBITDA

8.6x75.8

P/FCF

14.1x75.4

P/B

3.0x46.7

P/S

2.1x67.4

Div Yield

4.6%87.2

Momentum

52W High %

92%89.1

RS 6M

-25%34.6

SMA 50/200

1.06x69.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+14%30.2

Q Growth

32%64.8

FUNDAMENTALS

Market Cap

$949M

P/E (Forward)

12.4x

Gross Margin

52.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MEGA.BK are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
MEGA.BK	Mega Lifesciences Public Company Limited(you)	$949M	98	Strong Buy
CHG.BK	Chularat Hospital Public Company Limited	$519M	96	Strong Buy
BCH.BK	Bangkok Chain Hospital Public Company Limited	$835M	83	Strong Buy
SKR.BK	Sikarin Public Company Limited	$483M	92	Strong Buy
PR9.BK	Praram 9 Hospital Public Company Limited	$464M	89	Strong Buy
VIH.BK	Srivichaivejvivat Public Company Limited	$160M	98	Strong Buy
VIBHA.BK	Vibhavadi Medical Center Public Company Limited	$554M	71	Buy
BH.BK	Bumrungrad Hospital Public Company Limited	$4.8B	93	Strong Buy
RJH.BK	Rajthanee Hospital Public Company Limited	$135M	96	Strong Buy
RAM.BK	Ramkhamhaeng Hospital Public Company Limited	$643M	62	Hold

Peer medians: ROE 12.0% · P/E 15.4x · Gross margin 27.9%